{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T21:29:24Z","timestamp":1778707764377,"version":"3.51.4"},"reference-count":139,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.expneurol.2007.07.006","type":"journal-article","created":{"date-parts":[[2007,7,18]],"date-time":"2007-07-18T11:28:04Z","timestamp":1184758084000},"page":"12-21","source":"Crossref","is-referenced-by-count":41,"title":["Human-based studies on \u03b1-synuclein deposition and relationship to Parkinson's disease symptoms"],"prefix":"10.1016","volume":"209","author":[{"given":"Glenda M.","family":"Halliday","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"McCann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2007.07.006_bib1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","article-title":"Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system","volume":"25","author":"Abeliovich","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2007.07.006_bib2","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0166-2236(98)01276-4","article-title":"Ubiquitin, cellular inclusions and their role in neurodegeneration","volume":"21","author":"Alves-Rodrigues","year":"1998","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2007.07.006_bib3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1001\/archneur.59.1.102","article-title":"Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response","volume":"59","author":"Apaydin","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2007.07.006_bib4","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1212\/WNL.51.3.887","article-title":"Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein","volume":"51","author":"Arawaka","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2007.07.006_bib5","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1097\/00001756-199909090-00019","article-title":"Neural expression profile of alpha-synuclein in developing human cortex","volume":"10","author":"Bayer","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.expneurol.2007.07.006_bib6","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1073\/pnas.0407146102","article-title":"Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein","volume":"102","author":"Bertoncini","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2007.07.006_bib7","first-page":"141","article-title":"Limbic neuropathology in idiopathic Parkinson's disease with concomitant dementia","volume":"42","author":"Bertrand","year":"2004","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.expneurol.2007.07.006_bib8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0891-0618(00)00101-0","article-title":"Alpha-synuclein is not a requisite component of synaptic boutons in the adult human central nervous system","volume":"20","author":"Braak","year":"2000","journal-title":"J. Chem. Neuroanat."},{"issue":"Suppl 3","key":"10.1016\/j.expneurol.2007.07.006_bib9","first-page":"III\/1\u20135","article-title":"Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages)","volume":"249","author":"Braak","year":"2002","journal-title":"J. Neurol."},{"key":"10.1016\/j.expneurol.2007.07.006_bib10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2007.07.006_bib11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson's disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.expneurol.2007.07.006_bib12","first-page":"89","article-title":"Pathology associated with sporadic Parkinson's disease \u2014 where does it end?","author":"Braak","year":"2006","journal-title":"J. Neural Transm., Suppl."},{"key":"10.1016\/j.expneurol.2007.07.006_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00005072-199801000-00006","article-title":"Neuropathologic evidence that the Lewy body variant of Alzheimer disease represents coexistence of Alzheimer disease and idiopathic Parkinson disease","volume":"57","author":"Brown","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2007.07.006_bib14","first-page":"419","article-title":"Multiple system atrophy: cellular and molecular pathology","volume":"54","author":"Burn","year":"2001","journal-title":"Mol. Pathol."},{"key":"10.1016\/j.expneurol.2007.07.006_bib15","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0888-7543(95)80208-4","article-title":"The NACP\/synuclein gene: chromosomal assignment and screening for alterations in Alzheimer disease","volume":"26","author":"Campion","year":"1995","journal-title":"Genomics"},{"key":"10.1016\/j.expneurol.2007.07.006_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0304-3940(00)01247-7","article-title":"Alpha-synuclein immunoreactivity of huntingtin polyglutamine aggregates in striatum and cortex of Huntington's disease patients and transgenic mouse models","volume":"289","author":"Charles","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2007.07.006_bib17","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"Alpha-synuclein locus duplication as a cause of familial Parkinson's disease","volume":"364","author":"Chartier-Harlin","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2007.07.006_bib18","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.nbd.2006.08.021","article-title":"Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: is this the target for Parkinson's disease?","volume":"25","author":"Chu","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2007.07.006_bib19","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1074\/jbc.M108414200","article-title":"Lipid droplet binding and oligomerization properties of the Parkinson's disease protein alpha-synuclein","volume":"277","author":"Cole","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2007.07.006_bib20","doi-asserted-by":"crossref","first-page":"9678","DOI":"10.1074\/jbc.M409946200","article-title":"Metal-catalyzed oxidation of alpha-synuclein: helping to define the relationship between oligomers, protofibrils, and filaments","volume":"280","author":"Cole","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2007.07.006_bib21","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/jnnp.74.7.852","article-title":"Lewy body cortical involvement may not always predict dementia in Parkinson's disease","volume":"74","author":"Colosimo","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2007.07.006_bib22","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/3311","article-title":"Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease","volume":"4","author":"Conway","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2007.07.006_bib23","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1073\/pnas.97.2.571","article-title":"Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy","volume":"97","author":"Conway","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2007.07.006_bib24","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.1063522","article-title":"Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct","volume":"294","author":"Conway","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2007.07.006_bib25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2990.2006.00722.x","article-title":"Comparative study of commercially available anti-alpha-synuclein antibodies","volume":"32","author":"Croisier","year":"2006","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.expneurol.2007.07.006_bib26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/mds.21223","article-title":"The ups and downs of alpha-synuclein mRNA expression","volume":"22","author":"Dachsel","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2007.07.006_bib27","doi-asserted-by":"crossref","first-page":"9443","DOI":"10.1074\/jbc.273.16.9443","article-title":"Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes","volume":"273","author":"Davidson","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2007.07.006_bib28","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/jnen\/61.5.413","article-title":"Where does parkinson disease pathology begin in the brain?","volume":"61","author":"Del Tredici","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2007.07.006_bib29","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0140-6736(05)17829-5","article-title":"A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease","volume":"365","author":"Di Fonzo","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2007.07.006_bib30","doi-asserted-by":"crossref","first-page":"10209","DOI":"10.1021\/bi020139h","article-title":"Annular alpha-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes","volume":"41","author":"Ding","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.expneurol.2007.07.006_bib31","doi-asserted-by":"crossref","first-page":"8870","DOI":"10.1021\/bi034028+","article-title":"A peptide motif consisting of glycine, alanine, and valine is required for the fibrillization and cytotoxicity of human alpha-synuclein","volume":"42","author":"Du","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.expneurol.2007.07.006_bib32","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0002-9440(10)64781-5","article-title":"Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies","volume":"157","author":"Duda","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2007.07.006_bib33","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1532-5415.1969.tb01316.x","article-title":"Concentric hyalin intraneuronal inclusions of Lewy type in the brains of elderly persons (50 incidental cases): relationship to parkinsonism","volume":"17","author":"Forno","year":"1969","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.expneurol.2007.07.006_bib34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00401-006-0114-4","article-title":"Fragmentation of Golgi apparatus of nigral neurons with alpha-synuclein-positive inclusions in patients with Parkinson's disease","volume":"112","author":"Fujita","year":"2006","journal-title":"Acta Neuropathol. (Berl)"},{"key":"10.1016\/j.expneurol.2007.07.006_bib35","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"Alpha-synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.expneurol.2007.07.006_bib36","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(05)79256-4","article-title":"Multiple-system atrophy: a new alpha-synuclein disease?","volume":"352","author":"Gai","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2007.07.006_bib37","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0006-8993(94)91257-2","article-title":"Stability of cell size and nucleolar size in Lewy body containing neurons of substantia nigra in Parkinson's disease","volume":"637","author":"Gertz","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2007.07.006_bib38","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","article-title":"The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease","volume":"51","author":"Gibb","year":"1988","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2007.07.006_bib39","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1523\/JNEUROSCI.0094-07.2007","article-title":"Prime time for alpha-synuclein","volume":"27","author":"Gitler","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2007.07.006_bib40","doi-asserted-by":"crossref","first-page":"E115","DOI":"10.1038\/35041081","article-title":"Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease?","volume":"2","author":"Goldberg","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.expneurol.2007.07.006_bib41","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00401-001-0495-3","article-title":"Patterns of protein nitration in dementia with Lewy bodies and striatonigral degeneration","volume":"103","author":"Gomez-Tortosa","year":"2002","journal-title":"Acta Neuropathol. (Berl)"},{"key":"10.1016\/j.expneurol.2007.07.006_bib42","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1093\/brain\/awh584","article-title":"Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease","volume":"128","author":"Halliday","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2007.07.006_bib43","first-page":"99","article-title":"Critical appraisal of brain pathology staging related to presymptomatic and symptomatic cases of sporadic Parkinson's disease","author":"Halliday","year":"2006","journal-title":"J. Neural Transm., Suppl."},{"key":"10.1016\/j.expneurol.2007.07.006_bib44","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s004010100390","article-title":"Cortical Lewy body pathology in the diagnosis of dementia","volume":"102","author":"Harding","year":"2001","journal-title":"Acta Neuropathol. (Berl)"},{"key":"10.1016\/j.expneurol.2007.07.006_bib45","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/brain\/awf033","article-title":"Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe","volume":"125","author":"Harding","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2007.07.006_bib46","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1073\/pnas.040556597","article-title":"Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease","volume":"97","author":"Hartmann","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2007.07.006_bib47","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.febslet.2006.03.018","article-title":"Alpha-synuclein facilitates the toxicity of oxidized catechol metabolites: implications for selective neurodegeneration in Parkinson's disease","volume":"580","author":"Hasegawa","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.expneurol.2007.07.006_bib48","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S0140-6736(04)16901-8","article-title":"Pathogenetic mechanisms of parkin in Parkinson's disease","volume":"364","author":"Hattori","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2007.07.006_bib49","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/334345a0","article-title":"Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease","volume":"334","author":"Hirsch","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2007.07.006_bib50","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.brainresbull.2003.08.005","article-title":"BAX protein-immunoreactivity in midbrain neurons of Parkinson's disease patients","volume":"62","author":"Horowitz","year":"2003","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2007.07.006_bib51","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/00005072-199608000-00004","article-title":"Characterization of the precursor protein of the non-A beta component of senile plaques (NACP) in the human central nervous system","volume":"55","author":"Irizarry","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2007.07.006_bib52","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00005072-199804000-00005","article-title":"Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity","volume":"57","author":"Irizarry","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2007.07.006_bib53","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-X","article-title":"The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system","volume":"14","author":"Iwai","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2007.07.006_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s007020050001","article-title":"Cell death mechanisms in Parkinson's disease","volume":"107","author":"Jellinger","year":"2000","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2007.07.006_bib55","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00401-003-0725-y","article-title":"Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution \u2014 a pilot study","volume":"106","author":"Jellinger","year":"2003","journal-title":"Acta Neuropathol. (Berl)"},{"key":"10.1016\/j.expneurol.2007.07.006_bib56","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00702-004-0138-7","article-title":"Lewy body-related alpha-synucleinopathy in the aged human brain","volume":"111","author":"Jellinger","year":"2004","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2007.07.006_bib57","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1111\/j.1432-1033.2004.04250.x","article-title":"Alpha-synuclein-synaptosomal membrane interactions: implications for fibrillogenesis","volume":"271","author":"Jo","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.expneurol.2007.07.006_bib58","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1083\/jcb.143.7.1883","article-title":"Aggresomes: a cellular response to misfolded proteins","volume":"143","author":"Johnston","year":"1998","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.expneurol.2007.07.006_bib59","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0002-9440(10)63072-6","article-title":"Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model","volume":"159","author":"Kahle","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2007.07.006_bib60","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.expneurol.2005.10.024","article-title":"Lack of direct role of parkin in the steady-state level and aggregation of alpha-synuclein and the clearance of pre-formed aggregates","volume":"197","author":"Kim","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2007.07.006_bib61","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/mds.10683","article-title":"Alteration in alpha-synuclein mRNA expression in Parkinson's disease","volume":"19","author":"Kingsbury","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2007.07.006_bib62","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","article-title":"Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism","volume":"392","author":"Kitada","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2007.07.006_bib63","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00401-003-0705-2","article-title":"Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease","volume":"106","author":"Kovari","year":"2003","journal-title":"Acta Neuropathol. (Berl)"},{"key":"10.1016\/j.expneurol.2007.07.006_bib64","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1523\/JNEUROSCI.4564-06.2007","article-title":"Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies","volume":"27","author":"Kramer","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2007.07.006_bib65","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease","volume":"18","author":"Kruger","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2007.07.006_bib66","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1073\/pnas.96.7.3342","article-title":"Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease","volume":"96","author":"Lansbury","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2007.07.006_bib67","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0022-2836(02)00735-0","article-title":"Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils","volume":"322","author":"Lashuel","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.expneurol.2007.07.006_bib68","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1074\/jbc.M107045200","article-title":"Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form","volume":"277","author":"Lee","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2007.07.006_bib69","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0197-4580(02)00196-3","article-title":"Cell cycle aberrations by alpha-synuclein over-expression and cyclin B immunoreactivity in Lewy bodies","volume":"24","author":"Lee","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2007.07.006_bib70","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1523\/JNEUROSCI.0692-05.2005","article-title":"Intravesicular localization and exocytosis of alpha-synuclein and its aggregates","volume":"25","author":"Lee","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2007.07.006_bib71","doi-asserted-by":"crossref","first-page":"28212","DOI":"10.1074\/jbc.M011121200","article-title":"Muscarinic receptor stimulation induces translocation of an alpha-synuclein oligomer from plasma membrane to a light vesicle fraction in cytoplasm","volume":"276","author":"Leng","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2007.07.006_bib72","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3109\/00313028909061071","article-title":"The effects of progressive formaldehyde fixation on the preservation of tissue antigens","volume":"21","author":"Leong","year":"1989","journal-title":"Pathology"},{"key":"10.1016\/j.expneurol.2007.07.006_bib73","doi-asserted-by":"crossref","first-page":"11604","DOI":"10.1021\/bi010616g","article-title":"Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein","volume":"40","author":"Li","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.expneurol.2007.07.006_bib74","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0306-4522(02)00143-4","article-title":"Differential localization of alpha-, beta- and gamma-synucleins in the rat CNS","volume":"113","author":"Li","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2007.07.006_bib75","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1111\/j.1742-4658.2005.04792.x","article-title":"Inhibition of alpha-synuclein fibrillization by dopamine analogs via reaction with the amino groups of alpha-synuclein. Implication for dopaminergic neurodegeneration","volume":"272","author":"Li","year":"2005","journal-title":"Febs J."},{"key":"10.1016\/j.expneurol.2007.07.006_bib76","doi-asserted-by":"crossref","first-page":"12924","DOI":"10.1074\/jbc.M306390200","article-title":"Proteasomal inhibition by alpha-synuclein filaments and oligomers","volume":"279","author":"Lindersson","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2007.07.006_bib77","first-page":"1117","article-title":"Cytoplasmic inclusions in ganglion cells associated with parkinsonian states: a neurocellular change studied in 53 cases and 206 controls","volume":"35","author":"Lipkin","year":"1959","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2007.07.006_bib78","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nrn1867","article-title":"Adult neurogenesis and functional plasticity in neuronal circuits","volume":"7","author":"Lledo","year":"2006","journal-title":"Nat. Rev., Neurosci."},{"key":"10.1016\/j.expneurol.2007.07.006_bib79","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrn983","article-title":"Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein","volume":"3","author":"Lotharius","year":"2002","journal-title":"Nat. Rev., Neurosci."},{"key":"10.1016\/j.expneurol.2007.07.006_bib80","doi-asserted-by":"crossref","first-page":"38884","DOI":"10.1074\/jbc.M205518200","article-title":"Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line","volume":"277","author":"Lotharius","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2007.07.006_bib81","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0169-328X(91)90043-W","article-title":"The rat brain synucleins; family of proteins transiently associated with neuronal membrane","volume":"11","author":"Maroteaux","year":"1991","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.expneurol.2007.07.006_bib82","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","article-title":"Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal","volume":"8","author":"Maroteaux","year":"1988","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2007.07.006_bib83","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","article-title":"Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders","volume":"287","author":"Masliah","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2007.07.006_bib84","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s004010050843","article-title":"Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson's disease","volume":"95","author":"Mattila","year":"1998","journal-title":"Acta Neuropathol. (Berl)"},{"key":"10.1016\/j.expneurol.2007.07.006_bib85","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s004019900168","article-title":"Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease","volume":"100","author":"Mattila","year":"2000","journal-title":"Acta Neuropathol. (Berl)"},{"key":"10.1016\/j.expneurol.2007.07.006_bib86","doi-asserted-by":"crossref","first-page":"10068","DOI":"10.1523\/JNEUROSCI.0896-06.2006","article-title":"Cytosolic catechols inhibit alpha-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates","volume":"26","author":"Mazzulli","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2007.07.006_bib87","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2007.07.006_bib88","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(00)01701-8","article-title":"Proteasomal function is impaired in substantia nigra in Parkinson's disease","volume":"297","author":"McNaught","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2007.07.006_bib89","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1046\/j.1460-9568.2002.02301.x","article-title":"Aggresome-related biogenesis of Lewy bodies","volume":"16","author":"McNaught","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2007.07.006_bib90","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1006\/exnr.1997.6418","article-title":"Specific A10 dopaminergic nuclei in the midbrain degenerate in Parkinson's disease","volume":"144","author":"McRitchie","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2007.07.006_bib91","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nm0798-755","article-title":"Alpha synuclein in neurodegenerative disorders: murderer or accomplice?","volume":"4","author":"Mezey","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2007.07.006_bib92","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/jnen\/64.2.156","article-title":"Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: evidence from the Baltimore Longitudinal Study of Aging (BLSA)","volume":"64","author":"Mikolaenko","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2007.07.006_bib93","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0304-3940(96)13257-2","article-title":"The soluble form of Fas molecule is elevated in parkinsonian brain tissues","volume":"220","author":"Mogi","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2007.07.006_bib94","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00401-003-0769-z","article-title":"Absence of prostate apoptosis response-4 protein in substantia nigra of Parkinson's disease autopsies","volume":"107","author":"Moos","year":"2004","journal-title":"Acta Neuropathol. (Berl)"},{"key":"10.1016\/j.expneurol.2007.07.006_bib95","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1006\/exnr.2002.7929","article-title":"Demonstration of alpha-synuclein immunoreactivity in neuronal and glial cytoplasm in normal human brain tissue using proteinase K and formic acid pretreatment","volume":"176","author":"Mori","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2007.07.006_bib96","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00401-002-0555-3","article-title":"Lewy bodies in progressive supranuclear palsy","volume":"104","author":"Mori","year":"2002","journal-title":"Acta Neuropathol. (Berl)"},{"key":"10.1016\/j.expneurol.2007.07.006_bib97","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/01.jnen.0000230520.47768.1a","article-title":"Relationship among alpha-synuclein accumulation, dopamine synthesis, and neurodegeneration in Parkinson disease substantia nigra","volume":"65","author":"Mori","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2007.07.006_bib98","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.autneu.2006.03.006","article-title":"Neurogenesis and neural stem cells in the dorsal vagal complex of adult rat brain: new vistas about autonomic regulations \u2014 a review","volume":"126\u2013127","author":"Moyse","year":"2006","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.expneurol.2007.07.006_bib99","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/hmg\/ddh012","article-title":"Parkin is recruited into aggresomes in a stress-specific manner: over-expression of parkin reduces aggresome formation but can be dissociated from parkin's effect on neuronal survival","volume":"13","author":"Muqit","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2007.07.006_bib100","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1523\/JNEUROSCI.20-09-03214.2000","article-title":"Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons","volume":"20","author":"Murphy","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2007.07.006_bib101","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1097\/00005072-199912000-00007","article-title":"Alpha-synuclein immunoreactivity is present in axonal swellings in neuroaxonal dystrophy and acute traumatic brain injury","volume":"58","author":"Newell","year":"1999","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2007.07.006_bib102","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/1531-8257(199905)14:3<417::AID-MDS1005>3.0.CO;2-X","article-title":"Alpha-synuclein expression in substantia nigra and cortex in Parkinson's disease","volume":"14","author":"Neystat","year":"1999","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2007.07.006_bib103","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.bbrc.2003.08.059","article-title":"Parkin suppresses wild-type alpha-synuclein-induced toxicity in SHSY-5Y cells","volume":"309","author":"Oluwatosin-Chigbu","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.expneurol.2007.07.006_bib104","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.0305-1846.2001.00342.x","article-title":"Alpha-synuclein pathology is highly dependent on the case selection","volume":"27","author":"Parkkinen","year":"2001","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.expneurol.2007.07.006_bib105","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/jnen\/62.4.363","article-title":"Regional distribution of alpha-synuclein pathology in unimpaired aging and Alzheimer disease","volume":"62","author":"Parkkinen","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2007.07.006_bib106","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ana.20321","article-title":"Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia","volume":"57","author":"Parkkinen","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2007.07.006_bib107","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1440-1789.2005.00644.x","article-title":"Widespread and abundant alpha-synuclein pathology in a neurologically unimpaired subject","volume":"25","author":"Parkkinen","year":"2005","journal-title":"Neuropathology"},{"key":"10.1016\/j.expneurol.2007.07.006_bib108","doi-asserted-by":"crossref","first-page":"8053","DOI":"10.1523\/JNEUROSCI.21-20-08053.2001","article-title":"Induction of alpha-synuclein aggregation by intracellular nitrative insult","volume":"21","author":"Paxinou","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2007.07.006_bib109","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1523\/JNEUROSCI.22-08-03090.2002","article-title":"A role for alpha-synuclein in the regulation of dopamine biosynthesis","volume":"22","author":"Perez","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2007.07.006_bib110","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0896-6273(02)01125-X","article-title":"Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons","volume":"36","author":"Petrucelli","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2007.07.006_bib111","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.neurobiolaging.2004.10.006","article-title":"Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases","volume":"26","author":"Pletnikova","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2007.07.006_bib112","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2007.07.006_bib113","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/37.5.2495321","article-title":"Antigen preservation tests for immunocytochemical detection of cytoskeletal proteins: influence of aldehyde fixatives","volume":"37","author":"Riederer","year":"1989","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.expneurol.2007.07.006_bib114","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0022-510X(00)00337-3","article-title":"Widespread expression of alpha-synuclein and tau immunoreactivity in Hallervorden\u2013Spatz syndrome with protracted clinical course","volume":"177","author":"Saito","year":"2000","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2007.07.006_bib115","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/jnen\/62.6.644","article-title":"Accumulation of phosphorylated alpha-synuclein in aging human brain","volume":"62","author":"Saito","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2007.07.006_bib116","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/jnen\/63.7.742","article-title":"Lewy body-related alpha-synucleinopathy in aging","volume":"63","author":"Saito","year":"2004","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2007.07.006_bib117","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0002-9440(10)61113-3","article-title":"Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies","volume":"160","author":"Schlossmacher","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2007.07.006_bib118","doi-asserted-by":"crossref","first-page":"49874","DOI":"10.1074\/jbc.M309127200","article-title":"Altered fatty acid composition of dopaminergic neurons expressing alpha-synuclein and human brains with alpha-synucleinopathies","volume":"278","author":"Sharon","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2007.07.006_bib119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.febslet.2004.03.063","article-title":"Alpha-synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease","volume":"565","author":"Sidhu","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.expneurol.2007.07.006_bib120","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(02)00297-5","article-title":"Expression of alpha-synuclein, the precursor of non-amyloid beta component of Alzheimer's disease amyloid, in human cerebral blood vessels","volume":"326","author":"Tamo","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2007.07.006_bib121","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1074\/jbc.M310994200","article-title":"Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective","volume":"279","author":"Tanaka","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2007.07.006_bib122","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/exnr.2000.7489","article-title":"Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease","volume":"166","author":"Tatton","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2007.07.006_bib123","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00401-002-0622-9","article-title":"Glial involvement in diffuse Lewy body disease","volume":"105","author":"Terada","year":"2003","journal-title":"Acta Neuropathol. (Berl)"},{"key":"10.1016\/j.expneurol.2007.07.006_bib124","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0006-8993(97)00874-3","article-title":"Contribution of somal Lewy bodies to neuronal death","volume":"775","author":"Tompkins","year":"1997","journal-title":"Brain Res."},{"issue":"Suppl. 1","key":"10.1016\/j.expneurol.2007.07.006_bib125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1471-4159.2006.03719.x","article-title":"The dopamine transporter proteome","volume":"97","author":"Torres","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2007.07.006_bib126","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1073\/pnas.90.23.11282","article-title":"Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease","volume":"90","author":"Ueda","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2007.07.006_bib127","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1006\/bbrc.1994.2816","article-title":"Tissue-dependent alternative splicing of mRNA for NACP, the precursor of non-A beta component of Alzheimer's disease amyloid","volume":"205","author":"Ueda","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.expneurol.2007.07.006_bib128","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s004010050824","article-title":"Apolipoprotein E epsilon4 allele and progression of cortical Lewy body pathology in Parkinson's disease","volume":"95","author":"Wakabayashi","year":"1998","journal-title":"Acta Neuropathol. (Berl)"},{"key":"10.1016\/j.expneurol.2007.07.006_bib129","doi-asserted-by":"crossref","first-page":"13709","DOI":"10.1021\/bi961799n","article-title":"NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded","volume":"35","author":"Weinreb","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.expneurol.2007.07.006_bib130","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(05)70146-0","article-title":"Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study","volume":"4","author":"Williams","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2007.07.006_bib131","doi-asserted-by":"crossref","first-page":"32148","DOI":"10.1074\/jbc.M605965200","article-title":"Cytosolic proteins regulate alpha-synuclein dissociation from presynaptic membranes","volume":"281","author":"Wislet-Gendebien","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2007.07.006_bib132","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/978-3-211-45295-0_47","article-title":"Parkinson's disease: premotor clinico-pathological correlations","author":"Wolters","year":"2006","journal-title":"J. Neural Transm., Suppl."},{"key":"10.1016\/j.expneurol.2007.07.006_bib133","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/00005072-196207000-00012","article-title":"Concentric hyaline inclusion body formation in mental disease analysis of twenty-seven cases","volume":"21","author":"Woodard","year":"1962","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2007.07.006_bib134","series-title":"Laboratory Histopathology, A Complete Reference","author":"Woods","year":"1994"},{"key":"10.1016\/j.expneurol.2007.07.006_bib135","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s004010051005","article-title":"Cell death and apoptosis regulating proteins in Parkinson's disease \u2014 a cautionary note","volume":"97","author":"Wullner","year":"1999","journal-title":"Acta Neuropathol. (Berl)"},{"key":"10.1016\/j.expneurol.2007.07.006_bib136","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3233\/JAD-2001-3508","article-title":"Characterization of the human alpha-synuclein gene: genomic structure, transcription start site, promoter region and polymorphisms","volume":"3","author":"Xia","year":"2001","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.expneurol.2007.07.006_bib137","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/jnen\/59.7.585","article-title":"Alpha-synuclein inclusions in amygdala in the brains of patients with the parkinsonism\u2013dementia complex of Guam","volume":"59","author":"Yamazaki","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2007.07.006_bib138","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/00001756-200507130-00017","article-title":"Neuroprotection of Parkin against apoptosis is independent of inclusion body formation","volume":"16","author":"Yang","year":"2005","journal-title":"Neuroreport"},{"key":"10.1016\/j.expneurol.2007.07.006_bib139","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1385\/MN:31:1-3:243","article-title":"Alpha-synuclein and dopamine metabolism","volume":"31","author":"Yu","year":"2005","journal-title":"Mol. Neurobiol."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488607002725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488607002725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T05:28:41Z","timestamp":1587792521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488607002725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":139,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0014488607002725"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2007.07.006","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}